Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

07/08/2017 07:00

Aug 7 (Reuters)-  
             Towa Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               22.51               20.18            94.00     
                   (+11.6 pct)         (+3.8 pct)       (+10.7 pct)  
  Operating            2.38                1.34             8.60     
                   (+77.6 pct)         (-55.6 pct)      (+25.2 pct)  
  Recurring            2.93           loss 672 mln          8.50     
                                                        (+14.6 pct)  
  Net                  2.01             loss 1.10           5.80     
                                                        (+4.0 pct)   
  EPS              122.27 yen        loss 67.02 yen     353.59 yen   
  EPS Diluted      113.06 yen                                        
  Ann Div                               95.00 yen        95.00 yen   
  -Q2 div                               47.50 yen        47.50 yen   
  -Q4 div                               47.50 yen        47.50 yen   
   
  NOTE - Towa Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T  
  ((Tokyo Headline News Desk +813 6441 1812))